期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Cancer Biomarkers LetPub Score 5.1
51 ratings
Rate
Reputation 4.1 Influence 5.2 Speed 8.5 | ||||||||||||||||||||||||
期刊簡稱 | CANCER BIOMARK | ||||||||||||||||||||||||
ISSN | 1574-0153 | ||||||||||||||||||||||||
E-ISSN | 1875-8592 | ||||||||||||||||||||||||
h-index | 33 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.iospress.nl/journal/cancer-biomarkers/ | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/CBM | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | IOS Press | ||||||||||||||||||||||||
主題領域 | ONCOLOGY | ||||||||||||||||||||||||
出版國/地區 | NETHERLANDS | ||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
創刊年 | 2005 | ||||||||||||||||||||||||
每年文章數 | 91每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 6.10% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1574-0153%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 3.0 month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 | |
[Cancer Biomarkers] 的評論 | 撰寫評論 |
作者: 格洛丽亚瑞林 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-29 15:22:17 評論於 Review Speed: 1.0 | Submission hit rate: 75.0 Focus on research direction: Prognostic indicators; Experience sharing on liver cancer prognosis: 2023.3.18 submission---under review 2023.4.21 major revisions 8 | minor revisions 3 (pure clinical research, although there are many problems, they are all relatively easy to answer, did not require me to add data) 2023.5.08 resubmission---under review 2023.5.23 under review---process in decision 2023.5.28 acceptance(0) 讚! | 格洛丽亚瑞林 |
作者: 英洁可爱吗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-05 10:53:49 評論於 Review speed: 12.0 | Submission hit rate: 75.0 Emphasized research direction: tumor Experience sharing: It is a very slow journal, with a turnaround time of 8 months to 1 year(0) 讚! | 英洁可爱吗 |
作者: 降龙涵梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-21 09:41:15 評論於 So slow, it has been under review for a week. Is it too urgent to withdraw the submission now? #slowreview#(0) 讚! | 降龙涵梅 |
作者: Jill Will 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-14 16:38:02 評論於 I remember it was generated immediately(0) 讚! | Jill Will |
作者: Brady Whit 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-21 12:39:56 評論於 How long does it take to assign a number to the submitted manuscript?(0) 讚! | Brady Whit |
作者: 袈裟莉霞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-21 14:13:36 評論於 Review speed: 12.0 | Submission hit rate: 50.0 Sharing of experience: strongly discourage, 9 months for review, should have 1 rejection and 2 major revisions in the review comments, editor rejected after 1 month with very unprofessional reasons(0) 讚! | 袈裟莉霞 |
作者: Jill Will 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-18 20:09:08 評論於 I was accepted, it took nearly 4 months in total(0) 讚! | Jill Will |
作者: 削月连胜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-07 23:21:58 評論於 How is your article coming along?(0) 讚! | 削月连胜 |
作者: 削月连胜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-07 22:39:47 評論於 I have updated my schedule four times as well(0) 讚! | 削月连胜 |
作者: Zachary DuBois 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-21 14:05:07 評論於 I am already three months old(0) 讚! | Zachary DuBois |
作者: Jill Will 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-21 12:28:17 評論於 It's been 2 months, but it's still the same, only time is passing by(0) 讚! | Jill Will |
作者: 灵犀颖萓 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-15 09:34:47 評論於 Research focus: Tumor biomarkers Experience sharing: After submitting for nearly a month, the current status is "under review." What does that mean?(0) 讚! | 灵犀颖萓 |
作者: 削月连胜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-23 11:01:47 評論於 How are things now?(0) 讚! | 削月连胜 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:01:57 評論於 HIGHLIGHTS is just one of the requirements that authors must provide for journals under Elsevier. Not all journals include HIGHLIGHTS. The information provided by HIGHLIGHTS can help readers decide whether to read the paper further more quickly than reading the abstract(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 12:10:04 評論於 1. The study found that regular exercise can significantly reduce the risk of heart disease. 2. Participants who exercised at least three times a week had a 30% lower risk of developing heart disease. 3. Exercise was also shown to improve overall cardiovascular health and decrease inflammation in the body(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 20:54:56 評論於 What are the general requirements for the highlights section?(0) 讚! | Darlene Pepys |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 12:15:50 評論於 When do we need the highlights section?(0) 讚! | 修然小公主 |
作者: 静晨酱吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-06 18:05:54 評論於 My situation is the same(0) 讚! | 静晨酱吖 |
作者: Daniel Margaret 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-16 23:21:52 評論於 Have you placed a bet?(0) 讚! | Daniel Margaret |
作者: 落英士魁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-23 13:11:37 評論於 Review speed: 6.0 Emphasis on research direction: Tumor Experience sharing: It took more than 4 months from submission to receiving the first review comments, with four reviewers, two minor revisions and two major revisions. The result was a rejection, with the editor suggesting I resubmit after making the necessary changes(0) 讚! | 落英士魁 |
作者: 北风鸿振 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-19 22:58:34 評論於 Research focus: Tumors Experience sharing: Submitted after March 26th, minor revision on June 15th, major revision on June 26th, accepted on July 18th, feeling pretty good about it(0) 讚! | 北风鸿振 |
作者: 太枝mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-27 14:53:29 評論於 Can single gene bioinformatics without validation be submitted?(0) 讚! | 太枝mio |
作者: 志行可爱吗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-22 09:24:18 評論於 Review speed: 6.0 Emphasis on research direction: tumor Sharing experience: The review took five months, and the opinions of three reviewers were all minor issues. However, it was unexpectedly rejected in the end. It is a rubbish journal. I suggest being cautious about submitting to it(0) 讚! | 志行可爱吗 |
作者: 孤云新曼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-11-24 10:38:52 評論於 No clues... just click on the website link to check the status(0) 讚! | 孤云新曼 |
作者: 岱宗思美 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-11-21 08:15:51 評論於 I recently reviewed a domestic bioinformatics article, with a one-month deadline. I took ten days and gave minor revisions, but I could see that another reviewer rejected it outright. It has been sitting with the editor for 20 days now, so the main issue seems to be the slow handling by the editor(0) 讚! | 岱宗思美 |
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 |
Contact us